Search

The incidence rate of nonalcoholic fatty liver disease (NAFLD) is increasing. Diet is considered one of the main driving forces regulating the composition of intestinal microbiota, and the intestine and the liver are closely linked through the portal vein, so changes in gut microbiota may affect liver function and promote inflammation, insulin resistance, and steatosis, thereby causing NAFLD. This article elaborates on the relationship between diet, gut microbiota, and the liver and the research advances in how this axis promotes the progression of NAFLD, as well as the change in potential mechanism due to intestinal dysbacteriosis and related treatment methods. [ABSTRACT FROM AUTHOR]

Hepatic encephalopathy（ HE） greatly increases the economic burden of patients with liver disease and seriously affects their quality of life. HE has a complex pathological basis and various influencing factors,and its pathogenesis has not been fully clarified. There is still no specific effective therapy for this disease,and drug therapy often has an unsatisfactory clinical effect,as many drugs have poor tolerability,low compliance,and common adverse effects. This article analyzes and summarizes the non-drug therapies for hepatic encephalopathy including protein food and gut microbiota regulation,in order to provide new ideas and high-quality regimens for clinical treatment. [ABSTRACT FROM AUTHOR]